A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty
A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty
Recruiting · NCT07710430 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty | central precocious puberty, endocrine system disorder, gonadal disorder, precocious puberty | Recruiting | Phase 4 | 2026-07-29 | NCT07710430 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| LG Chem | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kangdong Sacred Heart Hospital | Seoul | South Korea | 7 |